| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/08/2023 | 76.68% | Wedbush | $6 → $5 | Maintains | Outperform |
| 08/04/2023 | 51.94% | Morgan Stanley | $4.6 → $4.3 | Maintains | Equal-Weight |
| 05/10/2023 | 112.01% | Wedbush | $8 → $6 | Maintains | Outperform |
| 05/10/2023 | 62.54% | Morgan Stanley | $5 → $4.6 | Maintains | Equal-Weight |
| 02/03/2023 | 76.68% | Morgan Stanley | $4.4 → $5 | Maintains | Equal-Weight |
| 11/04/2022 | 55.48% | Morgan Stanley | $6.1 → $4.4 | Maintains | Equal-Weight |
| 11/04/2022 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 11/04/2022 | 112.01% | JP Morgan | → $6 | Downgrades | Overweight → Neutral |
| 10/17/2022 | 115.55% | Morgan Stanley | $7.3 → $6.1 | Maintains | Equal-Weight |
| 08/08/2022 | 288.69% | Oppenheimer | $12 → $11 | Maintains | Outperform |
| 06/15/2022 | 182.69% | Morgan Stanley | $11 → $8 | Maintains | Equal-Weight |
| 05/06/2022 | 182.69% | Citigroup | $9 → $8 | Maintains | Sell |
| 02/28/2022 | 324.03% | Jefferies | → $12 | Initiates Coverage On | → Buy |
| 12/13/2021 | 377.03% | Wedbush | $11 → $13.5 | Upgrades | Neutral → Outperform |
| 11/18/2021 | 430.04% | JP Morgan | $13 → $15 | Upgrades | Neutral → Overweight |
| 11/11/2021 | 288.69% | Morgan Stanley | $9.8 → $11 | Upgrades | Underweight → Equal-Weight |
| 05/07/2021 | 214.49% | Morgan Stanley | $7.9 → $8.9 | Maintains | Underweight |
| 02/05/2021 | 179.15% | Morgan Stanley | $6.3 → $7.9 | Maintains | Underweight |
| 12/16/2020 | 122.61% | Morgan Stanley | $4.8 → $6.3 | Maintains | Underweight |
| 11/06/2020 | 69.61% | Morgan Stanley | $3.8 → $4.8 | Maintains | Underweight |
| 08/07/2020 | 34.28% | Morgan Stanley | $2.5 → $3.8 | Maintains | Underweight |
| 05/08/2020 | 23.67% | Wedbush | $2.5 → $3.5 | Maintains | Neutral |
| 05/08/2020 | -11.66% | Morgan Stanley | $2.2 → $2.5 | Maintains | Underweight |
| 03/25/2020 | -22.26% | Morgan Stanley | $3.5 → $2.2 | Maintains | Underweight |
| 03/16/2020 | -11.66% | Citigroup | $4.5 → $2.5 | Downgrades | Neutral → Sell |
| 10/03/2019 | 59.01% | Morgan Stanley | $5 → $4.5 | Maintains | Underweight |
| 08/02/2019 | 94.35% | Wedbush | $6 → $5.5 | Maintains | Neutral |
What is the target price for GoPro (GPRO)?
The latest price target for GoPro (NASDAQ: GPRO) was reported by Wedbush on November 8, 2023. The analyst firm set a price target for $5.00 expecting GPRO to rise to within 12 months (a possible 76.68% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for GoPro (GPRO)?
The latest analyst rating for GoPro (NASDAQ: GPRO) was provided by Wedbush, and GoPro maintained their outperform rating.
When is the next analyst rating going to be posted or updated for GoPro (GPRO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GoPro, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GoPro was filed on November 8, 2023 so you should expect the next rating to be made available sometime around November 8, 2024.
Is the Analyst Rating GoPro (GPRO) correct?
While ratings are subjective and will change, the latest GoPro (GPRO) rating was a maintained with a price target of $6.00 to $5.00. The current price GoPro (GPRO) is trading at is $2.83, which is out of the analyst's predicted range.